Last reviewed · How we verify
Mast cell leukemia
Approved treatments
- Rydapt · Novartis
Rydapt blocks the activity of the Kit receptor, which is involved in the growth and survival of cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mast cell leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Mast cell leukemia treatment landscape brief
- Mast cell leukemia treatment updates RSS
Frequently asked questions about Mast cell leukemia
What drugs treat Mast cell leukemia?
Tracked treatments include Rydapt.
What is the treatment for Mast cell leukemia?
Standard treatment for Mast cell leukemia includes Rydapt. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mast cell leukemia patent cliff · Mast cell leukemia CI report
- Treatment: Rydapt · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing